{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:54:57Z","timestamp":1761540897215},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.4065\/79.4.467","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:23:48Z","timestamp":1232760228000},"page":"467-475","source":"Crossref","is-referenced-by-count":18,"title":["Clinical Importance of Positive Test Results for Lupus Anticoagulant and Anticardiolipin Antibodies"],"prefix":"10.4065","volume":"79","author":[{"given":"Anne","family":"Proven","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachelina P.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin G.","family":"Moder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April","family":"Chang-Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laynalee K.","family":"Cardel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Heit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry A.","family":"Homburger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya M.","family":"Petterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa J.H.","family":"Christianson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William L.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4065\/79.4.467_bib1","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.4065\/79.4.467_bib2","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1258\/jrsm.95.7.336","article-title":"Antiphospholipid syndrome","volume":"95","author":"Keswani","year":"2002","journal-title":"J R Soc Med"},{"key":"10.4065\/79.4.467_bib3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s11926-000-0085-8","article-title":"Antiphospholipid antibodies and platelets","volume":"2","author":"De Jong","year":"2000","journal-title":"Curr Rheumatol Rep"},{"key":"10.4065\/79.4.467_bib4","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1538-7836.2003.00125.x","article-title":"Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease","volume":"1","author":"Arnout","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.4065\/79.4.467_bib5","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","article-title":"Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature","volume":"101","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.4065\/79.4.467_bib6","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMra002974","article-title":"The antiphospholipid syndrome","volume":"346","author":"Levine","year":"2002","journal-title":"N Engl J Med"},{"key":"10.4065\/79.4.467_bib7","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/archderm.1987.01660290064017","article-title":"Livedo reticularis associated with increased titers of anticardiolipin antibodies in systemic lupus erythematosus","volume":"123","author":"Weinstein","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.4065\/79.4.467_bib8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2133.1989.tb04170.x","article-title":"Skin lesions associated with circulating lupus anticoagulant","volume":"120","author":"Alegre","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.4065\/79.4.467_bib9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-116-4-293","article-title":"Valvular heart disease in the primary antiphospholipid syndrome","volume":"116","author":"Galve","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.4065\/79.4.467_bib10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0002-9343(90)90368-N","article-title":"Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus","volume":"89","author":"Leung","year":"1990","journal-title":"Am J Med"},{"key":"10.4065\/79.4.467_bib11","doi-asserted-by":"crossref","first-page":"971","DOI":"10.4065\/75.9.971","article-title":"Antiphospholipid syndrome and perioperative hemostatic management of cardiac valvular surgery","volume":"75","author":"Hogan","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/79.4.467_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/01.STR.18.1.257","article-title":"Cerebrovascular ischemia associated with lupus anticoagulant","volume":"18","author":"Levine","year":"1987","journal-title":"Stroke"},{"key":"10.4065\/79.4.467_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0002-9343(91)80009-B","article-title":"Cerebral ischemic events associated with endocarditis, retinal vascular disease, and lupus anticoagulant","volume":"90","author":"Pope","year":"1991","journal-title":"Am J Med"},{"key":"10.4065\/79.4.467_bib14","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/ard.47.8.681","article-title":"Chorea in systemic lupus erythematosus: association with antiphospholipid antibodies","volume":"47","author":"Khamashta","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"10.4065\/79.4.467_bib15","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/1529-0131(199906)12:3<212::AID-ART9>3.0.CO;2-M","article-title":"Thrombosis in systemic lupus erythematosus: the role of antiphospholipid antibody","volume":"12","author":"Qushmaq","year":"1999","journal-title":"Arthritis Care Res"},{"key":"10.4065\/79.4.467_bib16","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.50.3.368","article-title":"Chorea and the lupus anticoagulant","volume":"50","author":"Hodges","year":"1987","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.4065\/79.4.467_bib17","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1055\/s-0037-1614164","article-title":"Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests","volume":"84","author":"Galli","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.4065\/79.4.467_bib18","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/0003-4819-112-9-682","article-title":"Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance","volume":"112","author":"Love","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.4065\/79.4.467_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ajh.2830190308","article-title":"Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases","volume":"19","author":"Gastineau","year":"1985","journal-title":"Am J Hematol"},{"key":"10.4065\/79.4.467_bib20","first-page":"2131","article-title":"Classification of an intermediate group of patients with antiphospholipid syndrome and lupus-like disease: primary or secondary antiphospholipid syndrome?","volume":"26","author":"Weber","year":"1999","journal-title":"J Rheumatol"},{"key":"10.4065\/79.4.467_bib21","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/jama.1988.03720040042024","article-title":"The relationship between lupus anticoagulants and antibodies to phospholipid","volume":"259","author":"Triplett","year":"1988","journal-title":"JAMA"},{"key":"10.4065\/79.4.467_bib22","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S0889-8588(18)30284-3","article-title":"Hypercoagulability and thrombosis","volume":"6","author":"Bick","year":"1992","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.4065\/79.4.467_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-0037-1616204","article-title":"Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulants","volume":"86","author":"Arnout","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.4065\/79.4.467_bib24","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/ajcp\/25.12_ts.1417","article-title":"Evaluation of disorders of blood coagulation in the clinical laboratory","volume":"25","author":"Owen","year":"1955","journal-title":"Am J Clin Pathol"},{"key":"10.4065\/79.4.467_bib25","series-title":"The Diagnosis of Bleeding Disorders","first-page":"110","author":"Owen","year":"1975"},{"key":"10.4065\/79.4.467_bib26","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood.V68.4.869.869","article-title":"The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants","volume":"68","author":"Thiagarajan","year":"1986","journal-title":"Blood"},{"key":"10.4065\/79.4.467_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ajcp\/83.2.215","article-title":"Comparison of two simple tests for the lupus anticoagulant","volume":"83","author":"Exner","year":"1985","journal-title":"Am J Clin Pathol"},{"key":"10.4065\/79.4.467_bib28","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/ajcp\/79.6.678","article-title":"Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure","volume":"79","author":"Triplett","year":"1983","journal-title":"Am J Clin Pathol"},{"key":"10.4065\/79.4.467_bib29","first-page":"738","article-title":"Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results","volume":"62","author":"Loizou","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"10.4065\/79.4.467_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00003081-200103000-00007","article-title":"Testing for antiphospholipid antibodies: problems and solutions","volume":"44","author":"Pierangeli","year":"2001","journal-title":"Clin Obstet Gynecol"},{"key":"10.4065\/79.4.467_bib31","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1055\/s-0038-1649901","article-title":"Criteria for the diagnosis of lupus anticoagulants: an update","volume":"74","author":"Brandt","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.4065\/79.4.467_bib32","first-page":"51","article-title":"The prevalence of vascular occlusive disease associated with antiphospholipid syndromes","volume":"11","author":"Bacharach","year":"1992","journal-title":"Int Angiol"},{"key":"10.4065\/79.4.467_bib33","doi-asserted-by":"crossref","first-page":"524","DOI":"10.7326\/0003-4819-106-4-524","article-title":"The frequency of lupus anticoagulant in systemic lupus erythematosus: a study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anti-cardiolipin antibody level","volume":"106","author":"Petri","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.4065\/79.4.467_bib34","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJM198507183130304","article-title":"Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus","volume":"313","author":"Lockshin","year":"1985","journal-title":"N Engl J Med"},{"key":"10.4065\/79.4.467_bib35","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1055\/s-0037-1616548","article-title":"Persistent problems with standardization of immunoassays for anti-cardiolipin antibodies [letter]","volume":"86","author":"Fontaine","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.4065\/79.4.467_bib36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ajh.2830320215","article-title":"Simultaneous lupus anticoagulant and anticardiolipin assays and clinical detection of antiphospholipids","volume":"32","author":"Rosove","year":"1989","journal-title":"Am J Hematol"},{"key":"10.4065\/79.4.467_bib37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/art.1780300420","article-title":"Anticardiolipin antibody","volume":"30","author":"Lockshin","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.4065\/79.4.467_bib38","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/ard.47.5.364","article-title":"Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients","volume":"47","author":"Derksen","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"10.4065\/79.4.467_bib39","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/jcp.45.4.332","article-title":"Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus","volume":"45","author":"Ferro","year":"1992","journal-title":"J Clin Pathol"},{"key":"10.4065\/79.4.467_bib40","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ki.1995.352","article-title":"Antiphospholipids in hemodialysis patients: relationship between lupus anticoagulant and thrombosis","volume":"48","author":"Brunet","year":"1995","journal-title":"Kidney Int"},{"key":"10.4065\/79.4.467_bib41","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1182\/blood.V86.10.3685.bloodjournal86103685","article-title":"Antiphospholipid antibodies and venous thromboembolism","volume":"86","author":"Ginsberg","year":"1995","journal-title":"Blood"},{"key":"10.4065\/79.4.467_bib42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1191\/096120398678919688","article-title":"Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis","volume":"7","author":"Wahl","year":"1998","journal-title":"Lupus"},{"key":"10.4065\/79.4.467_bib43","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0002-9343(90)90458-P","article-title":"Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times","volume":"88","author":"Alving","year":"1990","journal-title":"Am J Med"},{"key":"10.4065\/79.4.467_bib44","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1365-2141.1997.d01-2055.x","article-title":"Risk of arterial thrombosis in patients with anticardiolipin antibodies and lupus anticoagulant","volume":"96","author":"Nojima","year":"1997","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.467_bib45","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1001\/archinte.1986.00360230069012","article-title":"Thrombosis, recurrent fetal loss, and thrombocytopenia: predictive value of the anticardiolipin antibody test","volume":"146","author":"Harris","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.4065\/79.4.467_bib46","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0002-9343(99)80014-X","article-title":"Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus","volume":"98","author":"Escalante","year":"1995","journal-title":"Am J Med"},{"key":"10.4065\/79.4.467_bib47","first-page":"525","article-title":"Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus","volume":"68","author":"Loizou","year":"1988","journal-title":"Q J Med"},{"key":"10.4065\/79.4.467_bib48","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0002-9343(88)80229-8","article-title":"Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus","volume":"85","author":"Kalunian","year":"1988","journal-title":"Am J Med"},{"key":"10.4065\/79.4.467_bib49","first-page":"437","article-title":"Influence of disease duration, continued followup and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus","volume":"20","author":"Perez-Vazquez","year":"1993","journal-title":"J Rheumatol"},{"key":"10.4065\/79.4.467_bib50","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/01.STR.28.9.1660","article-title":"IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thromboocclusive events and death: a prospective cohort study","volume":"28","author":"Levine","year":"1997","journal-title":"Stroke"},{"key":"10.4065\/79.4.467_bib51","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0029-7844(95)00497-1","article-title":"Anticardiolipin antibodies: clinical consequences of \u201clow titers.\u201d","volume":"87","author":"Silver","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.4065\/79.4.467_bib52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/ard.49.2.109","article-title":"Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients","volume":"49","author":"Cervera","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"10.4065\/79.4.467_bib53","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1600-0897.1992.tb00788.x","article-title":"The Hopkins Lupus Pregnancy Center: 1987-1991 update","volume":"28","author":"Petri","year":"1992","journal-title":"Am J Reprod Immunol"},{"key":"10.4065\/79.4.467_bib54","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1046\/j.1365-2141.2002.03949.x","article-title":"Anticardiolipin antibodies as a risk factor for venous thromboembolism in a population-based prospective study","volume":"119","author":"Runchey","year":"2002","journal-title":"Br J Haematol"},{"key":"10.4065\/79.4.467_bib55","first-page":"795","article-title":"IgG and IgM anticardiolipin antibodies in patients with lupus with anticardiolipin antibody associated clinical syndromes","volume":"15","author":"Cronin","year":"1988","journal-title":"J Rheumatol"},{"key":"10.4065\/79.4.467_bib56","first-page":"160","article-title":"Anticardiolipin antibodies during pregnancy","volume":"14","author":"Hedfors","year":"1987","journal-title":"J Rheumatol"},{"key":"10.4065\/79.4.467_bib57","first-page":"614","article-title":"Fall in antiphospholipid antibody at time of thromboocclusive episodes in systemic lupus erythematosus","volume":"16","author":"Drenkard","year":"1989","journal-title":"J Rheumatol"},{"key":"10.4065\/79.4.467_bib58","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/art.1780291021","article-title":"Discordant effects of prednisone on anticardiolipin antibodies and the lupus anticoagulant [letter]","volume":"29","author":"Derksen","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.4065\/79.4.467_bib59","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/ard.48.12.1023","article-title":"Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study","volume":"48","author":"Out","year":"1989","journal-title":"Ann Rheum Dis"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611627638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611627638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T01:17:30Z","timestamp":1589505450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611627638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0025619611627638"],"URL":"https:\/\/doi.org\/10.4065\/79.4.467","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}